Multi-feature computational framework for combined signatures of dementia in underrepresented settings

Tools

Moguilner, Sebastian and Birba, Agustina and Fittipaldi, Sol and Gonzalez-Campo, Cecilia and Tagliazucchi, Enzo and Reyes, Pablo and Matallana, Diana and Parra, Mario A and Slachevsky, Andrea and Farías, Gonzalo and Cruzat, Josefina and García, Adolfo and Eyre, Harris A. and La Joie, Renaud and Rabinovici, Gil and Whelan, Robert and Ibáñez, Agustin (2022) Multi-feature computational framework for combined signatures of dementia in underrepresented settings. Journal of Neural Engineering, 19. 046048. ISSN 1741-2552 (https://doi.org/10.1088/1741-2552/ac87d0)

[thumbnail of Moguilner-JNE-2022-Multi-feature-computational-framework-for-combined-signatures-of-dementia]
Preview
 Text. Filename: Moguilner_JNE_2022_Multi_feature_computational_framework_for_combined_signatures_of_dementia.pdf
Accepted Author Manuscript
License: Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 logo
Download (1MB)| Preview
[thumbnail of Moguilner_2022_Multi-feature computational framework for combined signatures of dementia in underrepresented settings]
Preview
 Text. Filename: Moguilner_2022_Multi-feature_computational_framework_for_combined_signatures_of_dementia_in_underrepresented_settings.pdf
Final Published Version
License: Creative Commons Attribution 4.0 logo
Download (2MB)| Preview

Abstract

Objective: The differential diagnosis of behavioral variant frontotemporal dementia (bvFTD) and Alzheimer's disease (AD) remains challenging in underrepresented, underdiagnosed groups, including Latinos, as advanced biomarkers are rarely available. Recent guidelines for the study of dementia highlight the critical role of biomarkers. Thus, novel cost-effective complementary approaches are required in clinical settings. Approach: We developed a novel framework based on a gradient boosting machine learning classifier, tuned by Bayesian optimization, on a multifeature multimodal approach (combining demographic, neuropsychological, MRI, and EEG/fMRI connectivity data) to characterize neurodegeneration using site harmonization and sequential feature selection. We assessed 54 bvFTD and 76 AD patients and 152 healthy controls (HCs) from a Latin American consortium (ReDLat). Main results: The multimodal model yielded high AUC classification values (bvFTD patients vs. HCs: 0.93 (±0.01); AD patients vs. HCs: 0.95 (±0.01); bvFTD vs. AD patients: 0.92 (±0.01)). The feature selection approach successfully filtered noninformative multimodal markers (from thousands to dozens). Results proved robust against multimodal heterogeneity, sociodemographic variability, and missing data. Significance: The model accurately identified dementia subtypes using measures readily available in underrepresented settings, with a similar performance than advanced biomarkers. This approach, if confirmed and replicated, may potentially complement clinical assessments in developing countries.

ORCID iDs

Moguilner, Sebastian, Birba, Agustina, Fittipaldi, Sol, Gonzalez-Campo, Cecilia, Tagliazucchi, Enzo, Reyes, Pablo, Matallana, Diana, Parra, Mario A ORCID logoORCID: https://orcid.org/0000-0002-2412-648X, Slachevsky, Andrea, Farías, Gonzalo, Cruzat, Josefina, García, Adolfo, Eyre, Harris A., La Joie, Renaud, Rabinovici, Gil, Whelan, Robert and Ibáñez, Agustin;
CORE (COnnecting REpositories)